Management of toxicities associated with the administration of taxanes.

Management of toxicities associated with the administration of taxanes.

Item
http://www.wikidata.org/entity/Q35194415
Ixabepilone (ixempra), a therapeutic option for locally advanced or metastatic breast cancer.Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.The role of taxanes in the management of gastroesphageal cancerEribulin mesylate in patients with refractory cancers: a Phase I study.Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.Taxane anticancer agents: a patent perspective.The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer.Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?Solid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animal.Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment.
P2860

Management of toxicities associated with the administration of taxanes.

Item
http://www.wikidata.org/entity/Q35194415
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Management of toxicities associated with the administration of taxanes.
@ast
Management of toxicities associated with the administration of taxanes.
@en
type
label
Management of toxicities associated with the administration of taxanes.
@ast
Management of toxicities associated with the administration of taxanes.
@en
prefLabel
Management of toxicities associated with the administration of taxanes.
@ast
Management of toxicities associated with the administration of taxanes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Management of toxicities associated with the administration of taxanes.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698